300 S.E. 2ND STREET,
FORT LAUDERDALE , FL, 33301-1923

Rank

Rank Universe

Summary

The fund seeks capital appreciation in the long term by investing in companies across any size outside the United States.

The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team invests in companies located anywhere in the world, including developing markets.

More

Link

Directors

Nov 13, 2023
  • Harris J. Ashton
  • David W. Niemiec
  • Edith E. Holiday
  • Ann Torre Bates
  • Gregory E. Johnson
  • Mary C. Choksi
  • Larry D. Thompson
  • Rupert H. Johnson, Jr.
  • Terrence J. Checki
  • J. Michael Luttig
  • Constantine D. Tseretopoulos

Chief Compliance Officer

  • Ted P. Becker

Fund Manager(s)

Price

  • $ 26.88 ( -0.07 )
    Nov 4, 2024
    Last Close
  • Net Assets
  • $8.6B
    Apr 23, 2024
  • Holding
  • 58
    Oct 23, 2024
    More

  • 52-Week High/Low
  • $27.88 - $22.83
  • Turnover
  • 44%
  • Expense Ratio
  • 1.29%

Company Name

Holding

AstraZeneca plc 4.04 %
UnitedHealth Group, Inc. 3.25 %
Taiwan Semiconductor Manufacturing Co. Ltd. 3.05 %
PNC Financial Services Group, Inc. (The) 2.96 %
Rolls-Royce Holdings plc 2.93 %
Microsoft Corp. 2.89 %
TJX Cos., Inc. (The) 2.85 %
Alphabet, Inc. 2.83 %
Unilever plc 2.82 %
Bank of America Corp. 2.78 %
More 2.78 %

Documents

Prospectus

Annual Reports

Performance

YTD

-

3 Year

7.35%

5 Year

17.28%

Best

32.55%

2003

Worst

-43.6%

2008

Alpha

TEGRX S&P 500

Chart +